Standout Papers

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism 2017 2026 2020 2023 473
  1. Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism (2017)
    Jeffrey I. Weitz, Anthonie W.A. Lensing et al. New England Journal of Medicine

Immediate Impact

54 standout
Sub-graph 1 of 22

Citing Papers

Neutrophil extracellular traps in homeostasis and disease
2024 Standout
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
2 intermediate papers

Works of Gerlind Holberg being referenced

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
2017 Standout
A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment
2013

Author Peers

Author Last Decade Papers Cites
Gerlind Holberg 591 506 286 9 794
Lu Ann Brooker 316 269 230 13 662
Rajalaxmi McKenna 337 346 395 16 827
Melissa A. Forgie 695 502 252 15 962
Sara Quenet 612 407 359 22 981
Ana Isabel Terleira‐Fernández 450 528 121 10 708
Billie L. Durn 315 404 135 18 968
Wilfred M. Huse 256 479 581 10 900
L Steidl 576 453 227 27 868
Joseph A. Caprini 452 332 192 21 733
Steven P. Ball 244 563 299 25 797

All Works

Loading papers...

Rankless by CCL
2026